See more : Transatlantic Mining Corp. (TRRGF) Income Statement Analysis – Financial Results
Complete financial analysis of Surgery Partners, Inc. (SGRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Surgery Partners, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- América Móvil, S.A.B. de C.V. (AMX.BA) Income Statement Analysis – Financial Results
- HDFC Asset Management Company Limited (HDFCAMC.NS) Income Statement Analysis – Financial Results
- Shanghai GenTech Co., Ltd. (688596.SS) Income Statement Analysis – Financial Results
- Ramkrishna Forgings Limited (RKFORGE.BO) Income Statement Analysis – Financial Results
- Jupiter Infomedia Limited (JUPITERIN.BO) Income Statement Analysis – Financial Results
Surgery Partners, Inc. (SGRY)
About Surgery Partners, Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.60M | 260.22M |
| Cost of Revenue | 2.10B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.20M | 669.33M | 254.18M | 169.84M | 159.35M |
| Gross Profit | 647.50M | 574.90M | 491.40M | 379.80M | 423.80M | 410.03M | 327.42M | 324.24M | 290.57M | 149.11M | 114.76M | 100.87M |
| Gross Profit Ratio | 23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 24.41% | 28.31% | 30.27% | 36.97% | 40.32% | 38.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Other Expenses | 0.00 | 112.40M | 60.90M | 48.60M | 75.10M | 63.67M | 25.33M | -3.73M | -119.91M | 21.21M | 17.85M | 14.32M |
| Operating Expenses | 319.50M | 214.60M | 164.90M | 145.70M | 163.70M | 157.23M | 156.37M | 123.66M | 111.83M | 52.66M | 44.18M | 39.58M |
| Cost & Expenses | 2.42B | 2.18B | 1.90B | 1.63B | 1.57B | 1.52B | 1.17B | 944.85M | 781.16M | 306.84M | 214.03M | 198.93M |
| Interest Income | 0.00 | 227.00M | 220.90M | 201.80M | 178.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 193.00M | 234.90M | 221.00M | 201.80M | 178.90M | 147.00M | 117.67M | 100.57M | 100.98M | 62.10M | 32.93M | 28.48M |
| Depreciation & Amortization | 118.10M | 149.60M | 137.90M | 134.20M | 116.50M | 67.44M | 51.93M | 39.55M | 34.55M | 15.06M | 11.66M | 11.21M |
| EBITDA | 480.80M | 460.00M | 401.00M | 277.80M | 336.60M | 144.68M | 251.88M | 245.23M | 59.39M | 65.87M | 69.89M | 72.49M |
| EBITDA Ratio | 17.53% | 19.86% | 20.32% | 18.35% | 18.81% | 18.58% | 19.00% | 21.05% | 10.12% | 27.96% | 28.89% | 27.86% |
| Operating Income | 328.00M | 345.20M | 302.20M | 246.60M | 235.90M | 77.84M | 158.23M | 196.48M | 144.75M | 50.81M | 58.23M | 60.45M |
| Operating Income Ratio | 11.96% | 13.59% | 13.58% | 13.26% | 12.88% | 4.39% | 11.80% | 17.15% | 15.08% | 12.60% | 20.46% | 23.23% |
| Total Other Income/Expenses | -193.00M | -234.90M | -221.00M | -201.80M | -181.30M | -147.00M | -75.95M | -104.30M | -220.89M | -62.10M | -32.93M | -29.31M |
| Income Before Tax | 135.00M | 110.30M | 81.20M | -18.80M | 54.60M | -69.17M | 82.29M | 92.18M | -76.14M | -11.29M | 25.30M | 31.97M |
| Income Before Tax Ratio | 4.92% | 4.34% | 3.65% | -1.01% | 2.98% | -3.90% | 6.14% | 8.05% | -7.93% | -2.80% | 8.89% | 12.29% |
| Income Tax Expense | 300.00K | 23.30M | 10.50M | -20.10M | 8.50M | 26.46M | 53.55M | 7.10M | -148.98M | 15.76M | 7.57M | 6.11M |
| Net Income | -11.90M | 87.00M | 70.70M | 1.30M | 46.10M | -205.71M | -52.99M | 9.45M | 1.43M | -65.90M | -9.06M | 1.92M |
| Net Income Ratio | -0.43% | 3.43% | 3.18% | 0.07% | 2.52% | -11.61% | -3.95% | 0.83% | 0.15% | -16.34% | -3.18% | 0.74% |
| EPS | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| EPS Diluted | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.08 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| Weighted Avg Shares Out | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.69M | 48.02M | 36.07M | 48.16M | 48.16M | 48.16M |
| Weighted Avg Shares Out (Dil) | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 49.00M | 48.19M | 37.46M | 48.16M | 48.16M | 48.16M |
Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin...
Surgery Partners (SGRY) Misses Q3 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.19 per share a year ago.
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2024 results before the market opens on Tuesday, November...
Here's Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire...
Here's Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire...
Surgery Partners (SGRY) Meets Q2 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago.
Surgery Partners, Inc. Announces Second Quarter 2024 Results Raises Full Year 2024 Guidance
BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024.
SGRY or MEDP: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Surgery Partners (SGRY) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Surgery Partners, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2024 results before the market opens on Tuesday, August...
Source: https://incomestatements.info
Category: Stock Reports